Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 20, 2021-- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021

Hirosaki University Hospital to become 6th Senhance hospital in Japan RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 6, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 4, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Paul LaViolette , who

Sapporo Medical University Hospital to become 5th Senhance hospital in Japan RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Sep. 29, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new

Loginov Moscow is the first Russian hospital to initiate a Senhance Surgical System program RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Sep. 27, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Sep. 8, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando , President and Chief Executive Officer, and Shameze Rampertab , Executive Vice President and Chief Financial Officer, will present at three upcoming

Additional Intelligent Surgical Unit™ (ISU™) features will further extend augmented intelligence leadership in surgery RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Sep. 1, 2021-- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Aug. 5, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial

Instrument platform expected to expand dexterity and add capability to Senhance ® Surgical System RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jul. 28, 2021-- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jul. 26, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board